A protein encoded by circular RNA reduced markers of iron-dependent neuronal injury in cell and mouse experiments. A single peer-reviewed study traced how ABCC1-677aa changes the location of a gene-regulating protein and releases two cellular defense systems from repression. The experiments model chronically reduced brain blood flow. Whether the same RNA and protein pathway operate in humans remains unconfirmed.
A single peer-reviewed study found reduced neuronal injury markers after increasing ABCC1-677aa, a protein encoded by the circular RNA circAbcc1. The work used cells deprived of oxygen and glucose, primary neurons and mice with chronically reduced blood flow to the brain. Its subject was ferroptosis, a cell-death process involving iron and oxidation of fats in cell membranes.[1]
ABCC1-677aa interacted with DLX1, a protein that regulates gene activity. The experiments supported its phosphorylation, a chemical modification, and movement from the nucleus into the surrounding cytoplasm. That change relieved repression of Gpx4 and Fsp1, two cellular defenses against ferroptosis. Increasing the encoded protein lowered lipid oxidation and iron-related injury indicators; reducing it changed them in the opposite direction. Mouse findings were consistent with this mechanism.[1]
Protein-fragment measurements and tests under normal cellular conditions examined whether the circular RNA genuinely encoded this protein. A modified RNA unable to produce it failed to restore protection in the same way. The authors have not established a corresponding human pathway, and the experimental cell line differs metabolically from living neural tissue. The culture’s timing pattern supplies no patient treatment window. Human dosing, safety and clinical benefit were not tested.[1]
